On June 1, Susan G. Komen launched its new Breast Cancer Clinical Trial Information Helpline for breast cancer patients and their loved ones. This helpline aims to 1) increase understanding of breast cancer clinical trials; 2) empower patients with information and resources they need to make an educated decision about clinical trial enrollment; and 3) make it easier for breast cancer patients to participate in and potentially benefit from, promising research. Komen’s Bold Goal is to reduce the current number of breast cancer deaths by 50% in the U.S. by 2026. Clinical trials are critical to the development of new cancer therapies and can help us work toward that goal. Yet very few breast cancer patients participate in clinical trials, either because they’re unaware of trials, are overwhelmed by the information they’re receiving, or not sure how to bring up the subject with their doctors. This Clinical Trial Information Helpline is here to help patients and loved ones get the answers they need, and potentially advance breast cancer research. The service is provided in Spanish and English, Monday – Friday from 9:00 a.m. – 10:00 p.m. ET. This helpline is answered by the current Komen Breast Care Helpline staff and the number is the same – 1-877 GO KOMEN (465-6636). Callers will hear the options for both helplines.

The komen.org Message Board forums are ONLY for those with breast cancer and their family members and friends as well as those at risk of developing breast cancer, and are for the purpose of supporting those living with breast cancer. These forums are not for use by industry or the media. We are not research subjects, so these forums are not for use by researchers. If you have questions about these forums, please use our Contact Us page located at ww5.komen.org/contact.aspx.